Oxygen Conserving Devices Market

Oxygen Conserving Devices Market Size, Share, Trends, Growth Analysis, By Product (Reservoir Oxygen Delivery Devices, Electromechanical Pulsing Devices, Transtracheal Catheters), By End User (Hospitals & Clinics, Long-term Care Units, Home Care), By Region - Global Market Insights 2022 to 2032

Analysis of Oxygen Conserving Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Oxygen Conserving Devices Market Outlook (2022-2032)

The global oxygen conserving devices market is surging from a US$ 1.6 billion valuation in 2022 to end up at a market valuation of US$ 4.8 million by 2032. Shipments of oxygen conserving devices are projected to increase at a stellar CAGR of 11.6% over the next ten years.

The market for oxygen conserving devices in the United States is anticipated to exhibit expansion at an impressive CAGR of 10.8% owing to the presence of developed healthcare infrastructure and the high availability of different types of portable oxygen conserving devices.

Report Attributes


Oxygen Conserving Devices Market Size (2022)

US$ 1.6 Billion

Projected Market Value (2032F)

US$ 4.8 Billion

Global Market Growth Rate (2022-2032)

11.6% CAGR

United Kingdom Market Growth Rate (2022-2032)

9.8% CAGR

Reservoir Oxygen Delivery Devices Segment Market Value (2032F)

US$ 1.1 Billion

China Market Growth Rate (2022-2032)

10.4% CAGR

Key Companies Profiled

  • Air Liquide Medical System
  • Foncepi Comercial Exportadora Ltd.
  • Inogen Inc.
  • GCE Group
  • Krober Medizintechnik
  • Precision Medical Inc.
  • Medline Industries Inc.
  • Inovo Inc.
  • GF Health Products Inc.
  • Invacare Corporation
  • Bostik
  • Drive DeVilbiss International

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Oxygen Conserving Device Sales Analysis (2017-2021) Vs. Market Metrics (2022-2032)

Increasing prevalence of chronic obstructive pulmonary disorders (COPD) across the world is anticipated to primarily promulgate the demand for oxygen conserving devices across the forecast period. Increasing demand for oxygen therapy for the treatment of various diseases such as autism, cancer, etc. is also expected to favor oxygen conserving device sales through 2032.

Growing awareness of chronic pulmonary disorders, increasing use of oxygen therapy, rising number of smokers, growing disposable income, development of innovative oxygen therapy conserving devices, increasing investments in R&D, and supportive government initiatives are other factors that are slated to bolster shipments of oxygen conserving devices throughout the forecast period.

Advancements in the development of pneumatic oxygen conservation devices and electronic oxygen conservation devices are expected to uncover untapped potential in emerging markets such as India, China, Japan, and Brazil. The Japan oxygen conserving devices market is set to rise at a notable CAGR of 9.4% through 2032.

Sales of oxygen conserving devices are projected to increase at a rapid CAGR of 11.6% over the next ten years. However, the high costs of oxygen conservation devices, lack of awareness in rural areas, and the presence of a complex regulatory framework are prospects that are expected to constrain overall oxygen conserving device demand going forward.

Oxygen conserving devices market forecast by Fact.MR

What Impact Does High Incidence of Chronic Obstructive Pulmonary Disorders Have on This Market?

“Increasing COPD-Affected Patient Pool Uplifting Oxygen Conserving Device Demand”

The world has witnessed a high occurrence of various types of lung diseases in recent years and this trend is expected to be followed through the forecast period as well. The advent of coronavirus in 2020 highlighted the importance of oxygen conservation devices in the treatment and management of the respiratory disorder that engulfed the world.

Oxygen conversation devices play a crucial role in the treatment of respiratory disorders as they allow controlled flow of oxygen as per patients’ requirements, improve patient outcomes, reduce wastage of oxygen, and are easy to use.

An increasing number of smokers and rising pollution levels have also resulted in more people being affected by chronic obstructive pulmonary disorders and are expected to bolster demand for oxygen conserving devices through 2032.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Aspects Impede Oxygen Conserving Device Sales?

“High Costs of Oxygen Conservation Devices to Hinder Market Potential”

Oxygen conserving devices are often priced at high cost owing to the use of advanced technologies in them. A complex regulatory framework for the approval of these devices is also a major hurdle that drives up the overall product development and manufacturing costs. All of these factors result in oxygen conserving devices priced on the expensive end and have a hindering effect on the overall market potential across the forecast period.

How Opportune is the Market for New Entrants?

“Increasing Focus on Healthcare R&D Bolstering Need for Innovative Devices”

Focus on healthcare has increased notably in recent years and the rising frequency of viral outbreaks is expected to bolster this focus over the coming years. Aspiring market players can focus on innovation to create novel devices with advanced technologies.

  • Solaire Initiatives Pvt Ltd., a start-up based in India has created a novel device that produces oxygen from water. The OM Redox device is capable of producing oxygen that is 3.5 times purer than what an oxygen concentrator provides. The technology deployed for this device can be scaled and made handy as well owing to the rising demand for portable oxygen conserving devices.
  • In March 2022, Venture Lab, a non-profit organization that promotes an entrepreneurial mindset in students announced applications for its Open Innovation Challenge. The start-up that wins this challenge will have a chance to collaborate and co-create with NGK. Key areas of focus of this challenge were respiratory illnesses, elderly care, and wound care.

Start-ups can participate in such challenges to gain more insights into their offerings and win chances to collaborate with industry leaders that can help them expand their business potential on a global scale.

All the key trends, opportunities, restraints, and challenges have been profiled in this revised oxygen conservation devices market report by analysts at Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

Why are Oxygen Conserving Device Manufacturers Attracted to the U.S.?

“Presence of Developed Healthcare Infrastructure & Favorable Reimbursement Policies”

The United States oxygen conserving devices market is predicted to witness lucrative growth opportunities over the coming years and this can be ascribed to the presence of key oxygen conserving device companies, developed healthcare infrastructure, and favorable reimbursement policies. The increasing incidence of COPD in the United States is also expected to propel oxygen conserving device sales in the country through 2032.

As per a study by the National Institutes of Health (NIH), nearly 12 million adults in the United States suffer from COPD and an additional 12 million suffer from it without ever being diagnosed. These metrics suggest that the demand for oxygen conservation devices (OCD) is predicted to rise at a CAGR of around 10.8% in the country over the next ten years

Category-wise Insights

How Will Demand for Reservoir Oxygen Delivery Devices Fare Over the Decade?

“Reservoir Oxygen Delivery Device Sales to Rise at Impressive CAGR through 2032”

The global oxygen conserving devices market, based on product, is segmented into reservoir oxygen delivery devices, electromechanical pulsing devices, transtracheal catheters, and others.

Demand for reservoir oxygen delivery devices is anticipated to progress at an exponential CAGR of around 11% over the next ten years and is predicted to account for a sales revenue value of nearly US$ 1.1 billion by the end of 2032.

These devices are also known as oxygen reservoir cannulas and have been available in the global market long before other types of devices. These devices are known to improve oxygen delivery efficacy and are mostly used for patients that have high flow requirements.

Other factors such as ease of use, reliability, and low costs are also expected to boost demand for reservoir oxygen delivery devices throughout the forecast period. Meanwhile, sales of transtracheal catheters are expected to increase at a CAGR of around 9.5% over the years to come.

Which End User Leads Global Oxygen Conserving Device Sales?

“Hospitals & Clinics Slated to Account for Dominant Market Share”

The global oxygen conserving devices market, based on end user, is segmented into hospitals & clinics, long-term care units, home care, and others.

Hospitals and clinics are projected to account for the highest sales of oxygen conserving devices over the coming years owing to increasing investments in healthcare infrastructure development and rising use of advanced equipment in healthcare establishments.

Increasing rate of hospitalization, growing use of oxygen in various disease treatments, and increasing popularity of oxygen therapies are other factors that drive oxygen conserving device shipments for hospitals and clinics across the forecast period.

Growing popularity of home care across the world is also anticipated to result in a hike in demand for oxygen conserving devices through 2032.

Competitive Landscape

Key stakeholders in the oxygen conserving devices market are expected to focus on strategies that help them expand their business network across the world. Companies in the oxygen conserving devices market are expected to ink new agreements that expand their sales and services to drive revenue generation capacity.

  • In August 2022, Belluscura PLC, a medical device developer announced that it had entered into an agreement with VGM Group Inc. Through this agreement VGM immediately gains access to Belluscura’s modular portable oxygen concentrator, X-PLOR.
  • In September 2022, CAIRE Inc., a leading oxygen equipment manufacturer expanded its service support network by making Repair Authority a part of its authorized service center network in the United States.

Oxygen Conserving Devices Industry Research Segments

  • By Product :

    • Reservoir Oxygen Delivery Devices
    • Electromechanical Pulsing Devices
    • Transtracheal Catheters
    • Others
  • By End User :

    • Hospitals & Clinics
    • Long-term Care Units
    • Home Care
    • Others
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

- FAQs -

What is the projected size of the oxygen conserving devices market?

The oxygen conserving devices market is predicted to reach US$ 4.8 billion by 2032.

Which is the leading regional market for oxygen conserving devices?

North America is expected to be the leading regional market over the decade.

What is the CAGR for the oxygen conserving devices market?

The global oxygen conserving devices market in 2022 is valued at US$ 1.6 billion.

What is the total market worth of oxygen conserving devices?

North America is expected to be the leading regional market over the decade.

Which key oxygen conserving device manufacturers are currently active in the industry?

Key manufacturers are Air Liquide Medical System, Foncepi Comercial Exportadora Ltd., Inogen Inc., GCE Group, Krober Medizintechnik, HERSILL S.L., Precision Medical Inc., Medline Industries Inc., and Inovo Inc.

What are the key driving factors for the market?

Rising incidence of COPD, increasing investments in healthcare R&D, and technological advancements are key factors pushing market expansion.

Oxygen Conserving Devices Market

Schedule a Call